Cytomegalovirus serology in young to mid‐adult life and decline of lung function
The Clinical Respiratory Journal · 2023-05 · 17 (5) · 468-472
DOI: 10.1111/crj.13600 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 16.03.2023. Verfasst von Raffaella Nenna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Asthma, Cytomegalovirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Introduction
Cytomegalovirus (CMV) seropositivity has been recently linked to severity and progression of asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). To date, no longitudinal study has addressed the relation of CMV serology to levels and decline of lung function in the general adult population.
Methods
We evaluated 403 participants from the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) who at enrollment were aged 28–55 years and completed lung function tests. During follow‐up, the 403 participants completed on average 7.2 lung function tests per subject for a total of 2908 observations over a mean period of 14.7 years. We tested CMV serology in serum samples from enrollment and categorized participants into low, medium, and high CMV serology based on tertiles. The relation of CMV serology at enrollment to lung function levels and decline during follow‐up was tested in multivariate random coefficients models.
Results
After full adjustment, participants in the highest CMV serology tertile had faster declines of forced expiratory volume in 1 s (FEV 1 ) and FEV 1 /forced vital capacity (FVC) compared with subjects in the lowest tertile (by −7.9 ml/year 95% confidence interval [−13.9 ml/year, −1.93 ml/year], and by −0.13%/year [−0.23%/year, −0.026%/year], respectively). These CMV effects were additive with those of cigarette smoking. No associations were found between CMV serology and FVC, indicating specific effects of CMV seropositivity on airflow limitation.
Conclusion
High CMV serology in young to mid‐adult life may be linked to increased COPD risk through an accelerated decline of lung function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona, USA.
- Department of Maternal Infantile and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
- Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
- Department of Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA.
ORCID-Profile: Stefano Guerra
Förderung
- NIEHS NIH HHS
- NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Nenna, R., Zhai, J., Spangenberg, A., Sherrill, D. L., Martinez, F. D., Halonen, M., & Guerra, S. (2023). Cytomegalovirus serology in young to mid‐adult life and decline of lung function. The Clinical Respiratory Journal, 17(5), 468-472. https://doi.org/10.1111/crj.13600
Vancouver
Nenna R, Zhai J, Spangenberg A, Sherrill DL, Martinez FD, Halonen M, et al. Cytomegalovirus serology in young to mid‐adult life and decline of lung function. The Clinical Respiratory Journal. 2023;17(5):468-472. doi:10.1111/crj.13600
BibTeX
@article{Nenna2023,
author = {Nenna, Raffaella and Zhai, Jing and Spangenberg, Amber and Sherrill, Duane L and Martinez, Fernando D and Halonen, Marilyn and Guerra, Stefano},
title = {Cytomegalovirus serology in young to mid‐adult life and decline of lung function},
journal = {The Clinical Respiratory Journal},
year = {2023},
volume = {17},
number = {5},
pages = {468--472},
doi = {10.1111/crj.13600}
}
EUVIMED